Alembic Pharma gets USFDA nod to market conjunctivitis treatment drug Posted By: Unknown March 22, 2019 Leave a Reply The approved product is therapeutically equivalent to the reference listed drug Optivar Ophthalmic Solution of Mylan Specialty L P. from Latest News https://ift.tt/2YfsPvR https://ift.tt/eA8V8J https://ift.tt/2LUVdkd Tweet Share Share Share Share
0 comments: